All lobbying filings
MADRIGAL PHARMACEUTICALS, INC.
Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company
Filing
1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 24, 2026
Expenses
$380,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Government bodies contacted
2
Lobbying activity
2
Issues related to CMMI drug pricing; 340B drug pricing
Most Favored Nation drug pricing; Issues related to CMMI drug pricing